It is absolutely scary to get an infection and run out of options to treat it. Broadly speaking, existing antibiotics are and are going to keep losing their effectiveness, if antibiotics and antimicrobials are not used effectively. In this episode, you will hear a discussion with Mr. Oliver Schacht, a corporate finance professional and expert in the molecular diagnostics industry. He is the CEO of OpGen which developed cloud-based software to identify, track and predict antibiotic-resistant infections. In this episode, he talks about the factors impacting the global issue of antimicrobial resistance, the role of rapid diagnostics in the process of effective prescribing of antibiotics, and also the political and economic factors impacting the development of antibiotics.
Enjoy the show, and if you’ll like what you hear, subscribe to be notified about new episodes automatically. And if you prefer podcasts, find Faces of digital health where ever you listen to podcasts.
Go to www.facesofdigitalhealth.com to browse through other episodes as well.
Leave a rating or a review www.lovethepodcast.com/facesofdigitalhealth